The July 22nd, 2014 start date for the Alternative Investment Fund Managers Directive (AIFMD) is fast approaching. If you are one of the many managers who have chosen not to register because of the costs, compliance burdens, and legal complexity associated with registration, you must forego actively marketing your products in the EU.
In fact, you may have stopped actively marketing in the region months ago.
The European market is not completely closed to you, however. Passive marketing through reverse solicitation is still permitted. In order to take advantage of this approach, you must maintain audit trails proving reverse inquiry on the part of European investors.
This is where FDN can be most helpful.
FDN Allows You to Receive and Track Reverse Solicitation
Not only does FDN enable you to receive specific reverse inquiry requests from investors, the system also captures profile access requests by investors in a historical audit trail. You can download these audit trails for compliance purposes to prove reverse inquiry to regulators and auditors.
You can also demonstrate with this data when specific investors have accessed different documents and information.
Any historical messages sent by investors to managers through the platform, for example requesting a conference call or a meeting, can be used in this context as well.
Open Up Europe
In other words, if you don’t want to register under AIFMD, but still wish to receive interest from European investors, FDN can help by providing a software solution enabling the retention of specific investor requests.
FDN was built with security and compliance in mind. This area of product focus has proven especially valuable and timely with respect to AIFMD.
If you would like to learn more about how FDN can help your firm receive auditable reverse inquiry, please email us at info@goFDN.com – we would love to hear from you.
Disclaimer: FDN does not provide legal advice or opinion. Those looking for professional legal advice on regulatory matters should seek appropriate counsel.